Preloader Close
#ISAD2023

Hall A - Aula Magna

Home / Scientific Information » Scientific Programme » Hall A - Aula Magna

Scientific Information

Hall A
Aula Magna
08:55-09:00

Welcome back
09:00-10:30

Symposium 6
Toward a personalized treatment in mood disorders:
Capturing the clinical and biological heterogeneity
Chair: Francesco Benedetti, IRCSS Ospedale San Raffaele, Italy
Improving healthcare of mood disorders with machine learning:
The gene-environment, immunoinflammatory and neuroimaging signatures
Benedetta Vai, IRCSS Ospedale San Raffaele, Italy
Inflammatory biomarkers for an early screening of
vulnerability and for a personalized intervention
Annamaria Cattaneo, IIRRCCS Fatebenefratelli Brescia, Italy
Identifying Depression Early in Adolescence (IDEA):
From sociodemographic to biological risk 
Valeria Mondelli, King’s College London, UK
Immunometabolic dysregulations in major depressive disorder:
implications and examples for personalized treatment
Femke Lamers, Amsterdam UMC, The Netherlands
10:30-11:15

Coffee Break & Poster Session C 
P-061 to P-090
11:15-12:00

Plenary Session 2
Risk and resilience in young people at risk for mood disorders
Manon Hillegers, Erasmus University Rotterdam, The Netherlands
12:00-13:00

Industry Session 2
13:00-14:00

Lunch Break and Exhibition
14:00-14:45

Lifetime Achievement Award Plenary Lecture
Sidney Kennedy, University of Toronto, Homewood Research Institute, Canada
14:45-16:15 

Symposium 8
Anhedonia: From reward processing to therapeutic targets
Chair: Sidney Kennedy, University of Toronto, Homewood Research Institute, Canada
Anhedonia: From reward processing to therapeutic targets           
Sidney Kennedy, University of Toronto, Homewood Research Institute, Canada
Overview of progress in brain mapping of reward processing
Argyris Stringaris, University of London, UK
Anhedonia in adolescence
Ciara McCabe, University of Reading, UK
Anhedonia: A transdiagnostic perspective with a focus on Substance Use Disorders
Giacomo d'Andrea, University of Chieti-Pescara, Italy
16:15-17:00

Coffee Break & Poster Session D 
P-091 to P-0119
17:00-18:15

Symposium 10
Antiglutamatergic Therapy in Difficult to Treat Depression and Bipolar Disorder:
Translational Application, Evidence and Mechanisms
Chair: Mario Juruena, King's College London, UK
Ketamine modulates reward-related areas:
Studies in depression and treatment-resistant depression and bipola
Mitul Mehta, King's College London, UK
Ketamine in treatment resistant unipolar and bipolar depression and bipolar depression -
which route is best?
Mario Juruena, King's College London, UK
The translational approach for antiglutamatergic therapy for mood disorders.
Rodrigo Machado-Vieira, University of Texas, USA
18:15-18:30

Prize Giving & Closing Ceremony